J. Obeso, M. Rodriguez-oroz, C. Goetz, C. Marin, J. Kordower et al., Missing pieces in the Parkinson's disease puzzle, Nature Medicine, vol.23, issue.6, pp.653-61, 2010.
DOI : 10.1038/nm.2165

H. Cheng, C. Ulane, and R. Burke, Clinical progression in Parkinson disease and the neurobiology of axons, Annals of Neurology, vol.322, issue.suppl 2, pp.715-740, 2010.
DOI : 10.1002/ana.21995

J. Tong, Y. Furukawa, A. Sherwin, O. Hornykiewicz, and S. Kish, Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain, Neurobiology of Disease, vol.41, issue.2, pp.458-68, 2011.
DOI : 10.1016/j.nbd.2010.10.017

J. Langston, L. Forno, J. Tetrud, A. Reeves, J. Kaplan et al., Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure, Annals of Neurology, vol.44, issue.4, pp.598-605, 1999.
DOI : 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F

E. Petroske, G. Meredith, S. Callen, S. Totterdell, and Y. Lau, Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment, Neuroscience, vol.106, issue.3, pp.589-601, 2001.
DOI : 10.1016/S0306-4522(01)00295-0

W. Dauer and S. Przedborski, Parkinson's Disease, Neuron, vol.39, issue.6, pp.889-909, 2003.
DOI : 10.1016/S0896-6273(03)00568-3

J. Javitch, D. Amato, R. Strittmatter, S. Snyder, and S. , Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity., Proceedings of the National Academy of Sciences, vol.82, issue.7, pp.2173-2180, 1985.
DOI : 10.1073/pnas.82.7.2173

M. Herkenham, M. Little, K. Bankiewicz, S. Yang, S. Markey et al., Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic study, Neuroscience, vol.40, issue.1, pp.133-58, 1991.
DOI : 10.1016/0306-4522(91)90180-V

L. Conforti, R. Adalbert, and M. Coleman, Neuronal death: where does the end begin?, Trends in Neurosciences, vol.30, issue.4, pp.159-66, 2007.
DOI : 10.1016/j.tins.2007.02.004

J. Duda, Parkinson's disease: the life cycle of the dopamine neuron, Ann N Y Acad Sci, vol.991, pp.1-360, 2003.

C. Taveggia, M. Feltri, and L. Wrabetz, Signals to promote myelin formation and repair, Nature Reviews Neurology, vol.52, issue.5, pp.276-87, 2010.
DOI : 10.1038/nrneurol.2010.37

R. Franklin and C. Ffrench-constant, Remyelination in the CNS: from biology to therapy, Nature Reviews Neuroscience, vol.2, issue.11, pp.839-55, 2008.
DOI : 10.1038/nrn2480

D. Mctigue and R. Tripathi, The life, death, and replacement of oligodendrocytes in the adult CNS, Journal of Neurochemistry, vol.10, issue.1, pp.1-19, 2008.
DOI : 10.1111/j.1471-4159.2008.05570.x

J. Levine, R. Reynolds, and J. Fawcett, The oligodendrocyte precursor cell in health and disease, Trends in Neurosciences, vol.24, issue.1, pp.39-47, 2001.
DOI : 10.1016/S0166-2236(00)01691-X

P. Horner, A. Power, G. Kempermann, H. Kuhn, T. Palmer et al., Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord, J Neurosci, vol.20, pp.2218-2246, 2000.

C. Barcia, S. Bahillo, A. Fernandez-villalba, E. Bautista, V. Poza et al., Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure, Glia, vol.373, issue.4, p.402, 2004.
DOI : 10.1002/glia.20015

P. Mcgeer and E. Mcgeer, Glial reactions in Parkinson's disease, Movement Disorders, vol.99, issue.4, pp.474-83, 2008.
DOI : 10.1002/mds.21751

E. Hirsch and S. Hunot, Neuroinflammation in Parkinson's disease: a target for neuroprotection?, The Lancet Neurology, vol.8, issue.4, pp.382-97, 2009.
DOI : 10.1016/S1474-4422(09)70062-6

S. Takagi, N. Hayakawa, H. Kimoto, H. Kato, and T. Araki, Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice, Journal of Neural Transmission, vol.14, issue.Suppl 3, pp.1553-1560, 2007.
DOI : 10.1007/s00702-007-0790-9

K. Wakabayashi, S. Hayashi, M. Yoshimoto, H. Kudo, and H. Takahashi, NACP/??-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson???s disease brains, Acta Neuropathologica, vol.99, issue.1, pp.14-20, 2000.
DOI : 10.1007/PL00007400

V. Jackson-lewis and S. Przedborski, Protocol for the MPTP mouse model of Parkinson's disease, Nature Protocols, vol.398, issue.1, pp.141-51, 2007.
DOI : 10.1038/nprot.2006.342

M. Candolfi, W. Xiong, K. Yagiz, C. Liu, A. Muhammad et al., Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics, Proceedings of the National Academy of Sciences, vol.107, issue.46, pp.20021-20027, 2010.
DOI : 10.1073/pnas.1008261107

D. Monte, D. Wu, E. Langston, and J. , Role of Astrocytes in MPTP Metabolism and Toxicity, Annals of the New York Academy of Sciences, vol.42, issue.1 Neurotoxins a, pp.219-247, 1992.
DOI : 10.1016/S0006-291X(88)80432-7

M. Horton, M. Rafay, D. Bigio, and M. , Pathological Evidence of Vacuolar Myelinopathy in a Child Following Vigabatrin Administration, Journal of Child Neurology, vol.49, issue.7, pp.1543-1549, 2009.
DOI : 10.1177/0883073809348796

K. Cliffer, J. Siuciak, S. Carson, H. Radley, J. Park et al., Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat, Annals of Neurology, vol.23, issue.1, pp.46-55, 1998.
DOI : 10.1002/ana.410430111

B. Lach, D. Grimes, B. Benoit, and A. Minkiewicz-janda, Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material, Acta Neuropathologica, vol.194, issue.4, pp.352-60, 1992.
DOI : 10.1007/BF00713525

J. Galvin, K. Uryu, V. Lee, and J. Trojanowski, Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha -, beta -, and gamma -synuclein, Proceedings of the National Academy of Sciences, vol.96, issue.23
DOI : 10.1073/pnas.96.23.13450

J. Cochiolo, R. Ehsanian, and D. Bruck, Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons, Journal of Neuroscience Research, vol.148, issue.1, pp.126-161, 2000.
DOI : 10.1002/(SICI)1097-4547(20000101)59:1<126::AID-JNR15>3.0.CO;2-L

V. Pickel, S. Beckley, T. Joh, and D. Reis, Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum, Brain Research, vol.225, issue.2, pp.373-85, 1981.
DOI : 10.1016/0006-8993(81)90843-X

Y. Smith, B. Bennett, J. Bolam, A. Parent, and A. Sadikot, Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey, The Journal of Comparative Neurology, vol.575, issue.1, pp.1-19, 1994.
DOI : 10.1002/cne.903440102

L. Kung, M. Force, D. Chute, and R. Roberts, Immunocytochemical localization of tyrosine hydroxylase in the human striatum: A postmortem ultrastructural study, The Journal of Comparative Neurology, vol.94, issue.1, pp.52-62, 1998.
DOI : 10.1002/(SICI)1096-9861(19980105)390:1<52::AID-CNE5>3.0.CO;2-P

C. Gerfen and D. Surmeier, Modulation of Striatal Projection Systems by Dopamine, Annual Review of Neuroscience, vol.34, issue.1, pp.441-66, 2011.
DOI : 10.1146/annurev-neuro-061010-113641

K. Nave and B. Trapp, Axon-Glial Signaling and the Glial Support of Axon Function, Annual Review of Neuroscience, vol.31, issue.1, pp.535-61, 2008.
DOI : 10.1146/annurev.neuro.30.051606.094309

M. Bozzali and L. Wrabetz, Axonal Signals and Oligodendrocyte Differentiation, Neurochemical Research, vol.29, issue.5, pp.979-88, 2004.
DOI : 10.1023/B:NERE.0000021242.12455.75

K. Jessen and R. Mirsky, Negative regulation of myelination: Relevance for development, injury, and demyelinating disease, Glia, vol.152, issue.14, pp.1552-65, 2008.
DOI : 10.1002/glia.20761

P. Charles, M. Hernandez, B. Stankoff, M. Aigrot, C. Colin et al., Negative regulation of central nervous system myelination by polysialylatedneural cell adhesion molecule, Proc Natl Acad Sci, vol.20, pp.7585-90, 2000.

B. Stankoff, C. Demerens, C. Goujet-zalc, M. Monge, F. Peyron et al., Transcription of myelin basic protein promoted by regulatory elements in the proximal 5??? sequence requires myelinogenesis, Multiple Sclerosis Journal, vol.16, issue.3, pp.125-157, 1996.
DOI : 10.1177/135245859600200302

F. Girolamo, M. Strippoli, M. Errede, V. Benagiano, L. Roncali et al., Characterization of oligodendrocyte lineage precursor cells in the mouse cerebral cortex: a confocal microscopy approach to demyelinating diseases, Ital J Anat Embryol, vol.115, pp.95-102, 2010.

F. Sim, C. Zhao, J. Penderis, and R. Franklin, The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation, J Neurosci, vol.22, pp.2451-2460, 2002.

S. Solly, J. Thomas, M. Monge, C. Demerens, C. Lubetzki et al., Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition, Glia, vol.12, issue.1, pp.39-48, 1996.
DOI : 10.1002/(SICI)1098-1136(199609)18:1<39::AID-GLIA4>3.0.CO;2-Z